Botulin toxin A in lower lid entropium correction (CROSBI ID 732272)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Ninčević, Ana ; Kalauz, Miro ; Knežević, Josip ; Masnec, Sanja
engleski
Botulin toxin A in lower lid entropium correction
INTRODUCTION/OBJECTIVES: to evaluate the clinical results and report the results of 12 cases of senile involutional entropion of the lower lid treated with botulinum toxin MATERIALS AND METHODS: Twelve patients with senile entropion were treated with an injection of botulinum toxin. The mean age was 67, 2±7, 3. The toxin (Botox ; Allergan Corporation, Irvine, CA) was supplied in a vial contained 100 units of freeze-dried botulinum toxin A. This was reconstituted and diluted with 2 ml of saline which resulted with a concentration of five units in 0.1. The reconstituted toxin was injected over the orbicularis oculi muscle subcutaneously 4 mm below the eyelash margin of lower eyelid at three sites with a 30-gauge needle. Five units of the toxin were injected in each site (15 units total). The patients were examined 7 days after the aplication, 30 days and then monthly up to 1 year. RESULTS: In all treated patients improvement of the eyelid margin was visible within three to four days after the injection with the duration which varied from 8 to 16 weeks. No complications or side effects of the treatment was recorded. CONCLUSION: Botulinum toxin A can be effective temporary treatment for senile lower lid entropion.
botulinum toxin, senile entropion, treatment
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
85-85.
2022.
objavljeno
10.26800/LV-144-supl2-CM02
Podaci o matičnoj publikaciji
Liječnički Vjesnik 144(Supl. 2)
Podaci o skupu
17th Croatian Student Summit Sensing the World: Otorhinolaryngology & Ophthalmology (CROSS17)
poster
27.04.2022-30.04.2022
Zagreb, Hrvatska
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)